Skip to main content
. 2012 Oct 17;2012:640835. doi: 10.1155/2012/640835

Figure 1.

Figure 1

IgG anti-GP2 antibodies in 225 patients with Crohn's disease (CD) and 225 patients with ulcerative colitis (UC). A cutoff of 20 AU/mL established by the manufacturer of the commercial ELISA (Generic Assays) is indicated with a dot line.